FDA Inspection 1028749 — South Texas Blood and Tissue Center
The FDA completed an inspection of South Texas Blood and Tissue Center on August 30, 2017 in San Antonio, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 30, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- San Antonio, TX (United States)